Patrick Phillips, PhD, MS, MA
|Clare College, University of Cambridge, UK||BA Hons||2003||Mathematics|
|University of Reading, UK||MSc||2005||Biometry|
|Clare College, University of Cambridge, UK||MA||2007||Mathematics|
|London School of Hygiene and Tropical Medicine, University of London, UK||PhD||2009||Medical Statistics|
|London School of Hygiene and Tropical Medicine, University of London, UK||PDip||2010||Postgraduate Diploma of the LSHTM by research in Epidemiology and Population Health|
As part of the UCSF Center for Tuberculosis, I am Associate Professor in Residence in the Division of Pulmonary and Critical Care Medicine with a secondary appointment in the Department of Epidemiology and Biostatistics. Prior to 2017 I was senior statistician at the MRC Clinical Trials Unit at UCL in London.
The objective of my research is to design, implement, and optimize clinical trials for new treatments for tuberculosis in order to deliver safer and more efficacious regimens for patients. I lead the Trial Design and Statistics core of the PanACEA consortium evaluating novel regimens for the treatment of TB, am consultant statistician for the US CDC-funded TB Trials Consortium (TBTC), and a member of the ACTG TB Transformative Science Steering Group. I have worked on late-phase clinical trials in tuberculosis for more than fifteen years, most recently as trial statistician in the STREAM Stage 1 and the TBTC/ACTG S31/A5349 phase III trials and vice-chair of ACTG A5414 SPECTR-TB. Ongoing methodological areas of interest include the evaluation and use of surrogate endpoints, the conduct and analysis of non-inferiority trials and trial design with a focus on adaptive designs. I am an associate editor for the journal BMC Trials.
With one click, see people who:
See more options in the Advanced Search tab